4.7 Article

Virus-like particles with FLAG-tagged envelope protein as a tetravalent dengue vaccine candidate

期刊

SCIENTIFIC REPORTS
卷 11, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41598-021-97038-4

关键词

-

资金

  1. Japan Agency for Medical Research and Development (AMED) [JP20fk0210040, JP20fk0210053, JP19fk0210022, JP19fk0108053, JP20fk0310102, JP20fk0310103, JP20fk0210075, JP20fk0108123, JP20fk0108102]
  2. Ministry of Education, Culture, Sports, Science and Technology, Japan [JP18H02661]
  3. NIH [P41-GM103311]

向作者/读者索取更多资源

This study developed a novel vaccine platform based on tetravalent dengue virus-like particles, which successfully induced neutralizing activity against all four DENV serotypes in mice, showing promise for future vaccine development against dengue and other emerging pandemics.
The global incidence of dengue, which is caused by dengue virus (DENV) infection, has grown dramatically in recent decades and secondary infection with heterologous serotype of the virus may cause severe symptoms. Efficacious dengue vaccines should be able to provide long-lasting immunity against all four DENV serotypes simultaneously. In this study, we constructed a novel vaccine platform based on tetravalent dengue virus-like particles (DENV-LPs) in which envelope (E) protein carried a FLAG tag sequence at the position located not only in the exterior loop on the protruding domain but outside of dimerization interface of the protein. We demonstrated an effective strategy to produce the DENV-LPs by transient transfection with expression plasmids for pre-membrane and E proteins of DENV-1 to DENV-4 in mammalian cells and to concentrate and purify them with one-step affinity chromatography. Characteristic features of VLPs such as particle size, shape and density were comparable to flavivirus-like particles reported. The neutralizing activity against all four DENV serotypes was successfully induced by immunization with the purified tetravalent VLPs in mice. Simple, one-step purification systems for VLP vaccine platforms using epitope-tagging strategy should be advantageous for vaccine development not only for dengue but for emerging pandemics in the future.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据